Protagenic Therapeutics, Inc. (PTIX)

USD 0.31

(3.0%)

Market Cap (In USD)

2.32 Million

Revenue (In USD)

-

Net Income (In USD)

-5 Million

Avg. Volume

5.44 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.452-1.87
PE
-0.27
EPS
-1.13
Beta Value
0.25
ISIN
US74365N2027
CUSIP
74365N103
CIK
1022899
Shares
7525680.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Garo H. Armen Ph.D.
Employee Count
-
Website
https://www.protagenic.com
Ipo Date
2021-04-27
Details
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.